The FY2025 (Dec) proxy of Viking Therapeutics names 18 peer companies for pay. Among Viking Therapeutics and these peers, CEO pay was the highest of 8 and total shareholder return was the highest of 8.
1st highest of 8in Viking Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
$10.4M$21.3M
1st highest of 8in Viking Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
$108$625
Pay peer group, FY2025 (Dec) proxy
| Madrigal Pharmaceuticals | ||
| United Therapeutics | ||
| BridgeBio Pharma | ||
| Revolution Medicines | ||
| Protagonist Therapeutics | ||
| Cytokinetics | ||
| Krystal Biotech | ||
| Akero Therapeutics, Inc. | Not disclosed | Not disclosed |
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Arrowhead Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Avidity Biosciences, Inc. | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Dyne Therapeutics, Inc. | Not disclosed | Not disclosed |
| Intra-Cellular Therapies, Inc. | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| SpringWorks Therapeutics, Inc. | Not disclosed | Not disclosed |
| Summit Therapeutics | Not disclosed | Not disclosed |
| Vaxcyte | Not disclosed | Not disclosed |
18 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.